Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proinsulin-specific CD8+ T cell
- Molecular classification
- T cell, Cytotoxic T lymphocyte (CTL)
01
Overview
Proinsulin-specific CD8+ T cells are a subset of cytotoxic T lymphocytes that recognize peptides derived from proinsulin, the precursor molecule to insulin, presented by HLA class I molecules on pancreatic beta cells. These autoreactive T cells play a central role in the pathogenesis of type 1 diabetes (T1D) by mediating immune destruction of insulin-producing beta cells. Strategies aimed at reducing their frequency or function (e.g., plasmid-based tolerization) have shown promise for preserving residual C-peptide secretion (a marker for endogenous insulin production).
- Other names
- Proinsulin-reactive CD8+ T cellAutoreactive CD8+ T cell specific for proinsulinProinsulin-specific cytotoxic T lymphocyte
02
Mechanism of action
Targeted killing of beta cells
03
Biological functions
Antigen recognitionCytotoxicityImmune responseBeta-cell destruction
04
Disease associations
Type 1 Diabetes (T1D)Autoimmunity
05
Safety considerations
Potential for broad immunosuppressionRisk of off-target effectsInduction of tolerance vs. complete ablation
06
Biomarkers
Frequency of proinsulin-specific CD8+ T cells in peripheral bloodFrequency of proinsulin-specific CD8+ T cells in pancreatic isletsC-peptide levels
Beyond the preview
Go deeper on Proinsulin-specific CD8+ T cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Proinsulin-specific CD8+ T cell.